Current Projects (PI Thomas Mindt)

  • Development of novel chelators for emerging new radiometals (OeAD, ASEA-UNINET, 3 years starting March 2025)
  • New applications for radiotherapy in nuclear medicine (Industry project)
  • Metabolically stabilized Peptidomimetics for improved tumor targeting (Institute project, 4 years starting April 2024)
  • Improved Nuclear Imaging by Pretargeting with Small Molecule (FWF, 14.08.2023 - 13.08.2027)
  • Bi-Metallic Complexes for Synergistic & Theranostic Applicatios (FWF, 01.08.2022 - 31.07.2025)
  • Markers for the activity of albumin-targeted platinum drugs (FWF, 01.08.2020 - 28.02.2025)
Former Projects (PI Thomas Mindt)
  • Radiostar: Novel Chelators for Radio-Lanthanides and-Actinides (FFG Bridge-1, 2020-2023)
  • Improved Tumour Targeting with Radiolabelled Peptido-mimetics (FWF, 2018-2023)